36 Series D investors focused on Biotech

What this selection covers

This guide contains 36 distinct directory identities matching sectors: Biotech; funding stages & types: Series D. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

Series D is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (35), Corporate Venture Capital (3), Family Office (3), Angel Network (2).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

For Series D, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

1. Check the current mandate and recent investments.
2. Confirm check size, lead or follow preference, and company eligibility.
3. Identify the relevant partner and published pitch route.
4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 36 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

Investor	Investor type	Research
5A5AM Ventures	Venture Capital	View profile ↗
ABAbingworth	Venture Capital	View profile ↗
AMAmadeus Capital Partners	Venture Capital	View profile ↗
ANAndreessen Horowitz	Venture Capital	View profile ↗
ASAscension Ventures	Venture Capital, Accelerator, Corporate Venture Capital	View profile ↗
ATAtomico	Venture Capital	View profile ↗
BABalderton Capital	Venture Capital	View profile ↗
CACayuga Venture Fund	Venture Capital	View profile ↗
COCorrelation Ventures	Venture Capital	View profile ↗
CRCRV	Venture Capital	View profile ↗
EAEarlybird Venture Capital	Venture Capital	View profile ↗
EQEQT Ventures	Venture Capital, Family Office	View profile ↗
FLFlagship Pioneering	Venture Capital	View profile ↗
FOForbion Capital Partners	Venture Capital	View profile ↗
FOFour Rivers Group	Venture Capital	View profile ↗
GAGaingels	Venture Capital, Angel Network	View profile ↗
GEGenoa Ventures	Venture Capital	View profile ↗
GGGGV Capital	Venture Capital	View profile ↗
GIGilde Healthcare	Venture Capital	View profile ↗
GLGlobal Founders Capital	Venture Capital, Family Office	View profile ↗
GOGolden Seeds	Venture Capital, Angel Network	View profile ↗
HBHBM Partners	Private Equity	View profile ↗
INIndex Ventures	Venture Capital	View profile ↗
INIndustrifonden	Venture Capital	View profile ↗
KAKapor Capital	Venture Capital, Family Office	View profile ↗
KHKhosla Ventures	Venture Capital	View profile ↗
LULux Capital	Venture Capital	View profile ↗
NONorwest	Venture Capital	View profile ↗
NONovartis Venture Fund	Venture Capital, Corporate Venture Capital	View profile ↗
NONovo Holdings	Venture Capital, Corporate Venture Capital	View profile ↗
PRProject A Ventures	Venture Capital	View profile ↗
QUQuiet Capital	Venture Capital	View profile ↗
SOSofinnova Partners	Venture Capital	View profile ↗
SVSV Health Investors	Venture Capital	View profile ↗
TATarget Global	Venture Capital	View profile ↗
TVTVM Capital	Venture Capital	View profile ↗

Related investor guides

United Kingdom · Biotech · Venture Capital

130 Venture Capital investors focused on Biotech targeting United Kingdom

205A8VAB

Explore guide ↗

United States · Biotech · Venture Capital

212 Venture Capital investors focused on Biotech targeting United States

19205A8V

Explore guide ↗

Biotech · Venture Capital

309 Venture Capital investors focused on Biotech

+N19205A

Explore guide ↗

Argentina · Biotech

19 investors focused on Biotech targeting Argentina

ANBOCODR

Explore guide ↗

Australia · Biotech

46 investors focused on Biotech targeting Australia

ABAIALAM

Explore guide ↗

Australia · Series D

29 Series D investors targeting Australia

AMAMANAR

Explore guide ↗